Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
84.74
+0.63 (0.74%)
Nov 21, 2024, 3:59 PM EST - Market closed

Company Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.

The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products.

The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name.

The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments.

The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products.

The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system.

The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc
Medtronic logo
Country Ireland
Founded 1949
Industry Medical Devices
Sector Healthcare
Employees 95,000
CEO Geoffrey Martha

Contact Details

Address:
Building Two, Parkmore Business Park West
Galway
Ireland
Phone 353 1 438 1700
Website medtronic.com

Stock Details

Ticker Symbol MDT
Exchange NYSE
Fiscal Year May - April
Reporting Currency USD
CIK Code 0001613103
CUSIP Number G5960L103
ISIN Number IE00BTN1Y115
SIC Code 3845

Key Executives

Name Position
Geoffrey Straub Martha Chairman of the Board and Chief Executive Officer
Sean M. Salmon Executive Vice President and President of Cardiovascular Portfolio
Brett A. Wall Executive Vice President and President of Neuroscience Portfolio
Gregory L. Smith Executive Vice President of Global Operations and Supply Chain
Gary Corona Senior Vice President of Global Financial Planning and Analysis and Interim Chief Financial Officer
Mark Ploof Senior Vice President of Global Operations and Business Services
Jennifer M. Kirk Senior Vice President, Global Controller and Chief Accounting Officer
Dr. Kenneth E. Washington Ph.D. Senior Vice President and Chief Technology and Innovation Officer
Dr. Laura Mauri M.D., M.Sc. Senior Vice President and Chief Scientific and Medical Officer
Ryan Weispfenning Vice President and Head of Investor Relations

Latest SEC Filings

Date Type Title
Nov 19, 2024 8-K Current Report
Oct 31, 2024 144 Filing
Oct 30, 2024 144 Filing
Oct 29, 2024 144 Filing
Oct 24, 2024 11-K Annual report of employee stock purchase, savings and similar plans
Oct 24, 2024 11-K Annual report of employee stock purchase, savings and similar plans
Oct 24, 2024 144 Filing
Oct 23, 2024 144 Filing
Oct 21, 2024 8-K Current Report
Oct 18, 2024 144 Filing